Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Vaxcyte, Inc.

61.91
-0.7100-1.13%
Volume:366.82K
Turnover:22.71M
Market Cap:9.21B
PE:-8.09
High:63.05
Open:62.30
Low:61.23
Close:62.62
52wk High:65.00
52wk Low:29.87
Shares:148.81M
Float Shares:136.00M
Volume Ratio:0.44
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.6496
EPS(LYR):-5.6333
ROE:-36.51%
ROA:-22.61%
PB:3.34
PE(LYR):-10.99

Loading ...

OverviewCompanyNewsFilings

Earning Preview: Vaxcyte, Inc. Q4 revenue is expected to be flat, and institutional views are cautiously bullish

Earnings Agent
·
Feb 17

Vaxcyte doses first participants in OPUS-3 trial

TIPRANKS
·
Feb 12

Vaxcyte Begins Phase 3 Trial of VAX-31 Pneumococcal Vaccine in Previously Vaccinated Adults

Reuters
·
Feb 12

Vaxcyte Doses First Participants in Opus-3 Phase 3 Trial Evaluating Vax-31 in Adults Previously Vaccinated With Lower-Valency Pneumococcal Vaccines

THOMSON REUTERS
·
Feb 12

Vaxcyte Inc: Topline Data Expected in Q4 of 2026

THOMSON REUTERS
·
Feb 12

Vaxcyte Inc. to report financial results and provide business update

Reuters
·
Feb 11

Analyst Rate

Buy
Buy
90.90%
Hold
9.09%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 05, 2026 Post-Mkt
Financial Report Announcement
May 06, 2026 Post-Mkt
Financial Report Announcement
Feb 24, 2026 Post-Mkt
Financial Report Announcement
Nov 04, 2025 Post-Mkt
Financial Report Announcement
Aug 06, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

-8.05
Current
-15.00
Sector Average
88.27%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-8.05
Maximum
-7.12
+1 STD
-9.60
Minimum
-29.14
-1 STD
-20.41
Average
-15.00

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.